Table 3.
Application | Nanocarrier | Core nanoparticles | Key features | Ref |
---|---|---|---|---|
Drug delivery | Hydrogel | nCur | High bioavailability, suitable for topical application. | [150–152] |
CS+atorvastatin/lovastatin | Anti-inflammatory and bone-enhancing effects. | [153] | ||
AgNPs | High bioavailability and lower toxicity. | [154] | ||
Nanofiber | PCL+Cip | Hydrophobic properties extending drug release time. | [201] | |
mPEGPCL+Protein kinase inhibitors | Long-term stable antibacterial effect. | [158] | ||
Nano Microneedle | Tetracycline | Reduction of mucosal immunity and extended antibacterial time. | [21] | |
Nanocapsules | AgNPs + antibiotics Nano-baicalin+CHX |
Stronger antibacterial effect and lower toxicity. Maintaining antibacterial and anti-inflammatory properties while reducing the side effects of CHX. |
[144] [147,148] |
|
Biomimetic cell membrane | Treg cell membrane | Endowing drugs with broad-spectrum immunomodulatory capabilities. | [141] | |
PTT | GNC | Controlled drug release. | [168] | |
PDT | sPDMA+ICG | Increasing the ability to target bacteria. | [173] | |
Tissue engineering | Inorganic nanoscaffold | NHAP | High osteoconductivity and biocompatibility. | [182] |
NHAP | Angiogenesis in early bone defect healing; Promotes osteogenesis | [181] | ||
NHAP+CG | Different morphologies have different effects on hiPSCs. | [183] | ||
NHAP+MgNPs | Improving antibacterial potential; Promotes cell proliferation; Migration and angiogenesis. | [185] | ||
NBG+AgNPs+CS | Enhanced antibacterial activity; Bioactivity; Controlled degradation; Non-toxic to cells | [189] | ||
NHAP | High osteoconductivity. | [202] | ||
Synthetic polymer scaffold | PLA | CS promotes the mechanical properties of PLA; PLA changes CS hydrophobic properties. |
[195] | |
PCL | Demonstrates both the antibacterial ability of MET and the osteogenic ability of NHAP. | [197] | ||
PLA | Improved mechanical properties and hydrophilicity. | [190] | ||
PCL PCL |
Good biocompatibility and good osteogenesis. Support materials that can be processed into specific structures by the MEW process |
[199] [185] |
||
Natural | CS+CC | Higher proliferative/metabolic activity. | [197] | |
Biodegradable | CS | Promoting the regeneration of oral soft tissue defects. | [179] | |
Polymer scaffold | CC+β-TCP | Improved compressive strength and cytocompatibility; Greatly enhanced periodontal tissue repair. |
[203] | |
CS | High load capacity enhancement; Excellent mechanical strengthening properties. | [198] |